Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$52.01 USD
+0.71 (1.38%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $52.03 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.78 | 1.08% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.69 per share. This reflects a positive earnings surprise of 14.49%. Look out for HALO's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.78 per share, reflecting a year-over-year increase of 5.41%.
Earnings History
Price & Consensus
Zacks News for HALO
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services